Note 1 - Nature of the Business and the Basis of Preparation (Details Textual) - USD ($) |
1 Months Ended | |||
|---|---|---|---|---|
Feb. 19, 2025 |
Jan. 24, 2025 |
Jan. 31, 2025 |
Mar. 31, 2026 |
|
| SEED Therapeutics Inc. [Member] | ||||
| Ownership Percentage in Subsidiaries | 13.62% | 36.51% | ||
| Seed [Member] | ||||
| Ownership Percentage in Subsidiaries | 38.03% | |||
| Seed [Member] | ||||
| Proceeds from Sale, Maturity and Collection of Investments | $ 7,354,000 | $ 35,418 | $ 35,418,000 |